Three patents currently held, every record listed here
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4 more records may belong here and await a decision; they are not counted.
The next term ends in Jan 2027. from the record
Of the 2 now held by other companies, 2 name Government of the United States of America as Represented by the Secretary of the Department of Health and Human Services Centers for Disease Control and Prevention as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
2
Ending by 2030
Jan 2027
Next term end
3
Patent families
When these terms end
Each bar runs from grant to computed term end. 2010 to 2038.
US 11,572,591
Methods and Assays for Subtyping Staphylococcus Aureus Clonal Complex 8 Strains
Apr 26, 2038
20162022202820342038
2 pending applications: term is not computable until grant.Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends May 2027 · High confidence
Also notable
Ends Jan 2027 · High confidence
Also notable
Ends Apr 2038 · High confidence
Dengue Serotype 2 Attenuated Strain
US 7,641,908
Renewed at every maintenance window since the 2010 grant; no more fees are due before its term ends in 2027.
Dengue Serotype 1 Attenuated Strain
US 7,641,907
Renewed at every maintenance window since the 2010 grant; no more fees are due before its term ends in 2027.
Methods and Assays for Subtyping Staphylococcus Aureus Clonal Complex 8 Strains
US 11,572,591
The newest of the three, granted 2023. It anchors the portfolio to 2038, later than anything else here.
Formerly held, still cited
Notable
Ends Dec 2031 · High confidence
Granted 2015 and renewed at every maintenance window due so far. Protection runs to 2031.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 17, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Methods and Assays for Subtyping Staphylococcus Aureus Clonal Complex 8 Strains | 1 in force | to Apr 2038 |
| Dengue Serotype 2 Attenuated Strain | 1 in force | to May 2027 |
| Dengue Serotype 1 Attenuated Strain | 1 in force | to Jan 2027 |
Patents held now
Soonest term end first.
Showing 1 to 3 of 3
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,641,907 | Dengue Serotype 1 Attenuated Strain In force · High confidence | In force | High confidence | |
| US 7,641,908 | Dengue Serotype 2 Attenuated Strain In force · High confidence | In force | High confidence | |
| US 11,572,591 | Methods and Assays for Subtyping Staphylococcus Aureus Clonal Complex 8 Strains In force · High confidence | In force | High confidence |
Also on record, not counted in the 3: 2 patents in force now held by others · 10 patents ended · 2 applications pending · 6 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.